255 related articles for article (PubMed ID: 1907440)
1. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
[TBL] [Abstract][Full Text] [Related]
2. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
[TBL] [Abstract][Full Text] [Related]
3. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
4. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
[TBL] [Abstract][Full Text] [Related]
7. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of acute coronary syndromes].
Ogawa H
J Cardiol; 1999 Mar; 33 Suppl 1():9-16. PubMed ID: 10342131
[TBL] [Abstract][Full Text] [Related]
9. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries.
Verheugt FW; ten Cate JW; Sturk A; Imandt L; Verhorst PM; van Eenige MJ; Verwey W; Roos JP
Am J Cardiol; 1987 May; 59(12):1075-9. PubMed ID: 3107367
[TBL] [Abstract][Full Text] [Related]
12. [Blood coagulation and fibrinolysis in arteriosclerosis].
Hoffmeister HM; Heller W; Seipel L
Z Kardiol; 1999 May; 88(5):315-23. PubMed ID: 10413853
[TBL] [Abstract][Full Text] [Related]
13. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.
Sakata K; Hoshino T; Yoshida H; Ono N; Ohtani S; Yokoyama S; Mori N; Kaburagi T; Kurata C; Urano T
Am Heart J; 1992 Oct; 124(4):854-60. PubMed ID: 1529901
[TBL] [Abstract][Full Text] [Related]
14. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
15. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
16. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
17. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
Mehta J; Mehta P; Lawson D; Saldeen T
J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma plasminogen activator inhibitor activity after coronary spasm.
Misumi I; Ogawa H; Masuda T; Sakamoto T; Okumura K; Yasue H
Int J Cardiol; 1993 Aug; 41(1):21-9. PubMed ID: 8225669
[TBL] [Abstract][Full Text] [Related]
19. [A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome].
Yan J; Huang Z; Liu R; Li L; Han C; Yang J
Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):817-20. PubMed ID: 11798724
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo.
Krishnamurti C; Alving BM
Semin Thromb Hemost; 1992 Jan; 18(1):67-80. PubMed ID: 1374195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
